Listed

Emergent BioSolutions Inc.: Form 10-Q for the period ended Jun 30, 2015

Filed with the SEC on Aug 6, 2015 and accepted by EDGAR at Aug 6, 2015, 10:39 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-04-01 to 2015-06-30$126.1mus-gaap:Revenues
Revenue6 months2015-01-01 to 2015-06-30$189.7mus-gaap:Revenues
Cost of revenue3 months2015-04-01 to 2015-06-30$27.3mus-gaap:CostOfGoodsSold
Cost of revenue6 months2015-01-01 to 2015-06-30$46.0mus-gaap:CostOfGoodsSold
Research and development3 months2015-04-01 to 2015-06-30$40.9mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2015-01-01 to 2015-06-30$79.6mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-04-01 to 2015-06-30$36.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2015-01-01 to 2015-06-30$70.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-04-01 to 2015-06-30$21.5mus-gaap:OperatingIncomeLoss
Operating income6 months2015-01-01 to 2015-06-30−$6.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2015-04-01 to 2015-06-30$1.6mus-gaap:InterestExpense
Interest expense6 months2015-01-01 to 2015-06-30$3.3mus-gaap:InterestExpense
Income tax3 months2015-04-01 to 2015-06-30$5.5mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2015-01-01 to 2015-06-30−$2.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-04-01 to 2015-06-30$14.1mus-gaap:NetIncomeLoss
Net income6 months2015-01-01 to 2015-06-30−$7.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-04-01 to 2015-06-30$0.32us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2015-01-01 to 2015-06-30−$0.19us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-04-01 to 2015-06-30$0.37us-gaap:EarningsPerShareBasic
Basic EPS6 months2015-01-01 to 2015-06-30−$0.19us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2015-04-01 to 2015-06-3047,410,413 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2015-01-01 to 2015-06-3038,216,524 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2015-01-01 to 2015-06-30−$63.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2015-01-01 to 2015-06-30$19.7mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-06-30$214.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-06-30$435.5mus-gaap:AssetsCurrent
Total assetsAt period end2015-06-30$943.3mus-gaap:Assets
Current liabilitiesAt period end2015-06-30$87.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-06-30$381.1mus-gaap:Liabilities
Long-term debtAt period end2015-06-30$253.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2015-06-30$562.3mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001367644-15-000037. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.